Your browser does not support iframes.
Miami Herald Index
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
AstraZeneca PLC ADS
(NY:
AZN
)
51.56
USD
-0.27 (-0.52%)
Official Closing Price
/ Updated:
6:40 PM EDT, May 17, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Stories about AstraZeneca PLC ADS
< Previous
1
2
3
4
5
6
7
8
9
...
69
70
Next >
U.S. Steel, Genomic Health and Other Stocks Insiders Are Buying
Today 15:54 EDT
Insiders may sell shares for any number of reasons, but conventional wisdom is that insiders really only buy shares of a company for one reason -- they believe the stock price will move higher and they...
Read More
category
GHDX
,
Benzinga
,
Murphy Oil
, and 35 more.
from
Latest Articles from Benzinga.com
AstraZeneca accelerates cancer drug testing
May 16, 2013
* Final-stage studies on olaparib, selumetinib start in H2
Read More
category
companyNews
from
Reuters: Company News
Benzinga's M&A Chatter for Wednesday May 15, 2013
May 15, 2013
The following are the M&A deals, rumors and chatter circulating on Wall Street for Wednesday May 15, 2013: Hearing Chatter Cisco May Bid $75/Share to Acquire Red Hat The Rumor:Shares of Red Hat (NYSE:...
Read More
category
S
,
ORCL
,
Benzinga
, and 14 more.
from
Latest Articles from Benzinga.com
UPDATE 1-Dish lines up banks to finance Sprint bid -sources
May 15, 2013
NEW YORK, May 15 (Reuters) - Dish Network Corp has lined up four banks to finance its $25.5 billion bid for Sprint Nextel Corp, escalating the bidding war against Japanese telecom company SoftBank...
Read More
category
companyNews
from
Reuters: Company News
Should I Buy Pfizer? 3 Pros, 3 Cons
May 15, 2013
Read More
category
NYSE:MRK
,
Stocks to Buy
,
NYSE:PFE
, and 3 more.
from
InvestorPlace - Latest Headlines
A taste for defensives sours prospects for European stocks
May 14, 2013
LONDON, May 14 (Reuters) - Defensive stocks such as healthcare companies, which often bring up the rear when markets rise, have led the gainers in 2013 as European bourses hit their highest in years,...
Read More
category
companyNews
from
Reuters: Company News
Benzinga's M&A Chatter for Monday May 13, 2013
May 13, 2013
The following are the M&A deals, rumors and chatter circulating on Wall Street for Monday May 13, 2013: AsiaInfo-Linkage to be Acquired by Group Led by CITIC Capital Partners for $12.00/Share in Cash...
Read More
category
AZN
,
Rumors
,
Benzinga
, and 12 more.
from
Latest Articles from Benzinga.com
Optimer Pharmaceuticals (OPTR) Jumps as AstraZeneca (AZN), Cubist (CBST) Submit First Round Bids
May 13, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8331970 for the full story.
Read More
from
StreetInsider.com News Articles
Six Superstars for Your Biotech Portfolio: John McCamant
May 09, 2013
Six Superstars for Your Biotech Portfolio: John McCamant Source: Tracy Salcedo-Chourr? of The Life Sciences Report (5/9/13) http://www.thelifesciencesreport.com/pub/na/15256 We are in the “golden age,”...
Read More
category
AZN
,
JNJ
,
ALKS
, and 8 more.
from
Bio-Wire.Com
U.S. spending on medicines fell for first time in 2012
May 08, 2013
May 9 (Reuters) - Patent expirations on big-name drugs such as Lipitor and Plavix has resulted in modestly less spending on medicines in the United States for the first time in at least 55 years,...
Read More
category
companyNews
from
Reuters: Company News
Small Companies Are Leading Innovation For New Drugs To Treat Depression
May 07, 2013
Back in 2011, two British professors, Guy Goodwin (Oxford University) and David Nutt (Imperial College London), co-authored a report entitled “Funding crisis threatens development of new treatments for...
Read More
category
NYSE:NVS
,
NYSE:MRK
,
NYSE:PFE
, and 2 more.
from
Forbes Real Time
Former AstraZeneca N.A. CEO to Serve as Senior Advisor to VIVUS (VVUS)
May 07, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8310523 for the full story.
Read More
from
StreetInsider.com News Articles
Even Pharma's Good Deeds Are Criticized
May 06, 2013
The pharmaceutical industry is far from perfect and previous posts have discussed some of these problems. However, this industry plays a major role in the discovery and development of new medicines....
Read More
category
NYSE:NVS
,
NYSE:MRK
,
NYSE:GSK
, and 1 more.
from
Forbes Real Time
Merck's Cholesterol Pill Win Is Already Drawing Fire
May 03, 2013
The Food and Drug Administration just approved Liptruzet, a new cholesterol-lowering pill that combines the generically available ingredient available in Pfizer's Lipitor with Merck's Zetia. Merck has...
Read More
category
NYSE:MRK
,
NYSE:PFE
,
NYSE:AZN
from
Forbes Real Time
PPH, SNY, GSK, AZN: ETF Outflow Alert
May 03, 2013
Symbols mentioned in this story: PPH, SNY, GSK, AZN Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''...
Read More
category
ETFs
from
ETF Channel
Big drugmakers think small with nanomedicine deals
May 03, 2013
* Early-stage research but scientists see momentum building
Read More
category
companyNews
from
Reuters: Company News
GSK, AZN, KERX, and RPTP Early Briefing and Review
May 02, 2013
from
ACCESSWIRE
Veeva Systems planning initial public offering - sources
April 30, 2013
April 30 (Reuters) - Life sciences-focused software company Veeva Systems is planning an initial public offering that could come in the third quarter and has selected banks to lead the deal, according...
Read More
category
companyNews
from
Reuters: Company News
PRESS DIGEST - British Business - April 26
April 25, 2013
The following are the top stories on the business pages of British newspapers. Reuters has not verified these stories and does not vouch for their accuracy.
Read More
category
companyNews
from
Reuters: Company News
Stocks Open Higher on Earnings, Jobless Claims; 3M Slumps
April 25, 2013
Stocks opened in positive territory Thursday, lifted by a batch of better-than-expected earnings and after an upbeat jobless claims report.
Read More
category
United Parcel Service
,
ASTRAZENECA PLC
,
Investing/Bonds
, and 18 more.
from
CNBC.com News
U.K. stocks decline, shrug off GDP data
April 25, 2013
Weak earnings from some of the U.K.’s heavyweights weigh on London’s benchmark stock index on Thursday, offsetting better-than-expected growth data for the country.
Read More
category
VZ
,
UL
,
UK:ADM
, and 17 more.
from
MarketWatch
US Stocks Seen Up Ahead of Earnings Blitz
April 25, 2013
U.S. stock index futures signaled a higher open early on Thursday, as investors await the busiest day of the earnings season, with reports from the likes of Amazon, Starbucks and Dow component 3M.
Read More
category
ASTRAZENECA PLC
,
Investing/Bonds
,
Dow Chemical Co
, and 20 more.
from
CNBC.com News
BRIEF-Astra CFO sees U.S. Brilinta growth accelerating at back-end of year
April 25, 2013
LONDON, April 25 (Reuters) - AstraZeneca PLC : * CFO says expects to see U.S. Brilinta growth accelerating at back-end of year
Read More
category
companyNews
from
Reuters: Company News
UPDATE 1-AstraZeneca Q1 sales tumble as generic losses bite deep
April 25, 2013
LONDON, April 25 (Reuters) - AstraZeneca's sales fell by a bigger-than-expected 13 percent in the first quarter as patent expiries took a heavy toll, underscoring the turnaround challenge facing...
Read More
category
companyNews
from
Reuters: Company News
AstraZeneca Q1 sales tumble as generic losses bite deep
April 25, 2013
LONDON, April 25 (Reuters) - AstraZeneca's sales fell by a bigger-than-expected 13 percent in the first quarter as patent expiries sent revenue from key medicines skidding lower, underscoring the...
Read More
category
companyNews
from
Reuters: Company News
Europe to Open Lower, UK GDP Ahead
April 25, 2013
European shares are expected to open lower on Thursday, ahead of the release of the U.K.'s first quarter growth estimate that could show that the U.K. has entered a "triple-dip" recession.
Read More
category
ASTRAZENECA PLC
,
Unilever NV
,
Dassault Systemes S/A/
, and 2 more.
from
CNBC.com News
AstraZeneca: 52-Week High Recently Eclipsed (AZN)
April 23, 2013
from
Comtex SmarTrend® News Briefs
Moody's sees pick-up in pharmaceutical industry M&A in 2013
April 22, 2013
LONDON, April 23 (Reuters) - Cash-rich drug companies are likely to make more acquisitions in 2013 after a thin year for deals in 2012, ratings agency Moody's Investors Service said on Tuesday.
Read More
category
companyNews
from
Reuters: Company News
AstraZeneca: 52-Week High Recently Eclipsed (AZN)
April 22, 2013
from
Comtex SmarTrend® News Briefs
AstraZeneca bets on nanotech with Bind Therapeutics deal
April 22, 2013
LONDON, April 22 (Reuters) - AstraZeneca is to pay privately held Bind Therapeutics as much as $200 million to develop a cancer medicine using the U.S. biotech company's nanotechnology drug delivery...
Read More
category
companyNews
from
Reuters: Company News
< Previous
1
2
3
4
5
6
7
8
9
...
69
70
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
Your browser does not support iframes.
Your browser does not support iframes.